| Advanced Enzyme Technologies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540025 |
NSE Symbol : ADVENZYMES |
P/E(TTM) : 28.56 |
|
ISIN Demat : INE837H01020 |
Div & Yield% : 1.66 |
EPS(TTM) : 10.94 |
|
Book Value(₹) : 59.96 |
Market Cap(₹Cr) : 3,496.59 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 115.75 | 125.02 | 87.21 | 100.87 | 77.38 | 85.96 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 115.75 | 125.02 | 87.21 | 100.87 | 77.38 | 85.96 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.08 | 53.85 | 4.53 | 1.43 | 1.66 | 53.88 |
| Total Income | 118.83 | 178.88 | 91.74 | 102.30 | 79.03 | 139.83 |
| Total Expenditure | 86.16 | 94.50 | 73.04 | 78.81 | 63.85 | 65.04 |
| PBIDT | 32.67 | 84.38 | 18.70 | 23.49 | 15.18 | 74.80 |
| Interest | 0.05 | 0.05 | 0.08 | 0.06 | 0.08 | 0.02 |
| PBDT | 32.62 | 84.33 | 18.62 | 23.43 | 15.11 | 74.78 |
| Depreciation | 3.00 | 2.93 | 3.11 | 2.89 | 2.78 | 2.62 |
| Tax | 7.28 | 7.44 | 3.55 | 5.33 | 3.07 | 4.95 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.05 | -0.03 | 0.91 | 0.03 | 0.13 | 0.15 |
| Reported Profit After Tax | 22.28 | 73.98 | 11.05 | 15.18 | 9.13 | 67.06 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 22.28 | 73.98 | 11.05 | 15.18 | 9.13 | 67.06 |
| EPS (Unit Curr.) | 1.99 | 6.61 | 0.99 | 1.36 | 0.82 | 6.00 |
| EPS (Adj) (Unit Curr.) | 1.99 | 6.61 | 0.99 | 1.36 | 0.82 | 6.00 |
| Calculated EPS (Unit Curr.) | 1.99 | 6.61 | 0.99 | 1.36 | 0.82 | 6.00 |
| Calculated EPS (Adj) (Unit Curr.) | 1.99 | 6.61 | 0.99 | 1.36 | 0.82 | 6.00 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.97 | 26.45 | 3.95 | 5.43 | 3.26 | 23.99 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.97 | 26.45 | 3.95 | 5.43 | 3.26 | 23.99 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 200.00 | 200.00 |
| Equity | 22.38 | 22.38 | 22.38 | 22.38 | 22.37 | 22.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.22 | 67.49 | 21.44 | 23.29 | 19.62 | 87.02 |
| PBDTM(%) | 28.18 | 67.45 | 21.35 | 23.23 | 19.53 | 86.99 |
| PATM(%) | 19.25 | 59.17 | 12.67 | 15.05 | 11.80 | 78.01 |